Abridge, AI Startup Automation Medical Notes, assured the E series in the amount of $ 300 million with a valuation of $ 5.3 billion, according to Wall Street Journal. Round, led by Andreesen Horowitz with the participation of Khosl Ventures, follows $ 250 million of the company (*4*)Collecting Funds February with a valuation of $ 2.75 billion.
7-year-old Abridge is widely considered a leader in the increasingly crowded medical scratching market, mainly due to the early entrance and integration with Epic systems, dominant health record software.
In the first quarter, Abridge reached $ 117 million in contractual annual repetitive revenues (the indicator that features all signed repetitive contacts, including customers who were still not implemented), Information submitted last month.
Along with the obtaining of funds, Abridge announced that it is expanding to transform medical notes from patients’ visits into AI medical codes, an offer that makes the company directly competitive with startups, equivalent to Codametrix and the function of its partner Epic systems.
Abridge, founded by the cardiologist Shiv Rao, claims that his technology AI is used by over 150 the largest healthcare systems in the USA